- ￥3660
- 南京万木春生物
- 进口/国产
- WM-24JY548
- 2025年12月13日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 英文名：
/
- 库存：
现货库存
- 供应商：
/
- 肿瘤类型：
/
- 细胞类型：
/
- 品系：
/
- 组织来源：
ATCC/DSMZ/ECACC
- 相关疾病：
/
- 物种来源：
人或动物
- 免疫类型：
/
- 细胞形态：
/
- 是否是肿瘤细胞：
/
- 器官来源：
/
- 运输方式：
常温或干冰
- 年限：
/
- 生长状态：
/
- 规格：
T25
|
种属 |
小鼠 |
|
组织来源 |
正常肺组织 |
|
传代比例 |
1:2传代 |
|
完全培养基配置 |
基础培养基500ml ；生长添加剂5ml ；胎牛血清25ml ；双抗5ml |
|
简介 |
肺微血管内皮细胞构成半选择性屏障 ，该屏障对于肺气体交换 ，调节液体和可溶物在血液与肺间质之间的流动具有重 要意义。它还具有代谢功能 ，可以执行一定的非呼吸功能。在肺损伤中 ，肺微血管内皮细胞是活性氧类的重要靶细胞 之一。在肺炎的发生过程中 ，神经体液介质和氧化剂作用于内皮细胞 ，使得细胞间隙渗透性增加 ，蛋白质由血液进入 间质。细胞间隙渗透性的增加导致低氧血症 ，出现成人呼吸窘迫综合征和非心源性肺水肿。 |
|
形态 |
上皮细胞样 ，多角形细胞样 |
|
生长特征 |
贴壁生长 |
|
细胞检测 |
CD31免疫荧光染色为阳性免疫荧光鉴定 ，细胞纯度可达90%以上 ，不含有HIV-1、HBV、HCV、支原体、细菌、酵 母和真菌等。 |
|
倍增时间 |
每周 2 至 3 次 |
|
换液频率 |
2-3天换液一次 |
|
培养条件 |
气相 ：空气 ，95% ；二氧化碳 ，5%。 温度 ：37摄氏度 ，培养箱湿度为70%-80%。 |
|
冻存条件 |
冻存液 ：90%FBS ，DMSO 10%, 或使用非程序冻存液 ：官网货号JY-H040 |
|
产品使用 |
仅限于科学研究 ，不可作为动物或人类疾病的治疗产品使用。 |
cancer genomics data. We compared expression and enrichment levels of 787 immune-related genes and 23 immune gene-sets among TP53-mutated GCs, TP53-wildtype GCs, and normal tissue, and explored the correlations between p53-mediated pathways and immune activities in clinical validation; 3. perspectives on how to realize the potential of machine learning models and to overcome the perceptual and practical limits of visual scoring.Autologous tumor cell-based vaccines (ATVs) are emerging as a transformable approach for personalized immunotherapy, but patients were treated with ERT/αPD-1 or plus chemotherapy. Radiation-induced pneumonitis occurred in 1 of 26 patients receiving thoracic ERT. There were two cases of grade III toxicity cancer-associated fibroblasts, but also immune cells of both the innate and adaptive system (tumour-associated macrophages, neutrophils, natural killer cells, and T and B lymphocytes), and
Questions/purposes: Our objectives were (I) characterize the epidemiology of de novo bone metastasis with respect to patient demographics, (II) characterize the incidence by primary site, age, and sex (2010-2015), and (III) compare survival of de novo metastatic cancer patients with and without bone metastasis.
Methods: This is a retrospective, population-based study using nationally representative data from the Surveillance, Epidemiology, and End Results program, 2010-2015. Incidence rates by year of diagnosis, annual percentage changes, Kaplan-Meier, univariate and multiple Cox regression models are included in the analysis.
Results: Of patients with cancer in the SEER database, 5.1% were diagnosed with metastasis to bone, equaling ~18.8 per 100,000 bone metastasis diagnoses in the US per year (2010-2015). For adults >25, lung cancer is the most common primary site (2015 rate: 8.7 per 100,000) with de novo bone metastases, then prostate and breast primaries (2015 rates: 3.19 and 2.38 per 100,000, respectively). For patients <20 years old, endocrine cancers and soft tissue sarcomas are the most common primaries. Incidence is increasing for prostate (Annual Percentage Change (APC) = 4.6%, P < 0.001) and stomach (APC = 5.0%, P = 0.001) cancers. The presence of de novo bone metastasis was associated with a limited reduction in overall survival (HR = 1.02, 95%, CI = [1.01-1.03], p < 0.001) when compared to patients with other non-bone metastases.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验/responders to GC immunotherapy. TP53 mutations frequently occur in GC and are associated with unfavorable clinical outcomes in GC. We performed a comprehensive characterization of the associations between TP53 mutations and immune activities in GC based on two large-scale GC
Autoimmune and Infectious Diseases
Concerning autoimmune diseases (e.g., RA and MS) and chronic infectious diseases like TB, can autophagy modulation ameliorate disease progression? Targeting autophagy in several animal models of
技术资料暂无技术资料 索取技术资料
